ArticleThe EMBO journal2021
ELIXIR-EXCELERATE: establishing Europe's data infrastructure for the life science research of the future.
Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- A maturity model framework for federated networks of trusted research environments.Frontiers in digital health · 2026Article
- Non-healthcare system interventions and COVID-19 daily cases: a multilevel time series analysis.BMC public health · 2025Article
- The Federated European Genome-Phenome Archive as a global network for sharing human genomics data.Nature genetics · 2025Article
- REDIportal: toward an integrated view of the A-to-I editing.Nucleic acids research · 2025Article
- Fostering and sustaining collaborative innovation: Insights from ELIXIR Europe's life science Communities.F1000Research · 2025Article
- Dynamic configuration and data security for bioinformatics cloud services with the Laniakea Dashboard.NAR genomics and bioinformatics · 2024Article
- FAIRsoft-a practical implementation of FAIR principles for research software.Bioinformatics (Oxford, England) · 2024Article
- Using text-mining to measure the scientific impact and legacy of ELIXIR, a distributed research infrastructure for life science data.F1000Research · 2024Article
- Metadata integrity in bioinformatics: Bridging the gap between data and knowledge.Computational and structural biotechnology journal · 2023Review
- The ELIXIR Biodiversity Community: Understanding short- and long-term changes in biodiversity.F1000Research · 2023Article
- The European Genome-phenome Archive in 2021.Nucleic acids research · 2022Article
- GA4GH Passport standard for digital identity and access permissions.Cell genomics · 2021Article
- Laniakea@ReCaS: exploring the potential of customisable Galaxy on-demand instances as a cloud-based service.BMC bioinformatics · 2021Article
- DOME: recommendations for supervised machine learning validation in biology.Nature methods · 2021Article
- ELIXIR: providing a sustainable infrastructure for life science data at European scale.Bioinformatics (Oxford, England) · 2021Article
- ELIXIR-EXCELERATE: establishing Europe's data infrastructure for the life science research of the future.The EMBO journal · 2021Article
- Recommendations for connecting molecular sequence and biodiversity research infrastructures through ELIXIR.F1000Research · 2021Article
- Data Integration Challenges for Machine Learning in Precision Medicine.Frontiers in medicine · 2021Review
- Bioimage analysis workflows: community resources to navigate through a complex ecosystem.F1000Research · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A new inter-governmental research infrastructure, ELIXIR, aims to unify bioinformatics resources and life science data across Europe, thereby facilitating their mining and (re-)use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.